These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 23832632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y, Suarez-Cuervo C, Erekosima N, Kim JM, Ramanathan M, Segal JB, Lin SY.
    J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
    [Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward D, Segal JB.
    JAMA; 2013 Mar 27; 309(12):1278-88. PubMed ID: 23532243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    Lin SY, Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Ward D, Chelladurai Y, Segal JB.
    ; 2013 03 27. PubMed ID: 23638484
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subcutaneous immunotherapy.
    Roche AM, Wise SK.
    Int Forum Allergy Rhinol; 2014 Sep 27; 4 Suppl 2():S51-4. PubMed ID: 25182356
    [Abstract] [Full Text] [Related]

  • 9. [Cluster immunotherapy in allergic rhinoconjunctivitis].
    Klimek L, Pfaar O.
    MMW Fortschr Med; 2011 Feb 17; 153(7):34-6. PubMed ID: 21648138
    [No Abstract] [Full Text] [Related]

  • 10. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E.
    Clin Ther; 2012 Oct 17; 34(10):2072-81. PubMed ID: 23063373
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR, Wang XN, Jiang HD, Wang QY, Li YC, Lin J, Jin K, Zhang HL, Li CC.
    Zhonghua Er Ke Za Zhi; 2012 Oct 17; 50(10):726-31. PubMed ID: 23302557
    [Abstract] [Full Text] [Related]

  • 12. Specific immunotherapy-indications and mode of action.
    Brehler R, Klimek L, Kopp MV, Christian Virchow J.
    Dtsch Arztebl Int; 2013 Mar 17; 110(9):148-58. PubMed ID: 23533561
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.
    Creticos PS, Esch RE, Couroux P, Gentile D, D'Angelo P, Whitlow B, Alexander M, Coyne TC.
    J Allergy Clin Immunol; 2014 Mar 17; 133(3):751-8. PubMed ID: 24332263
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA, Casale TB, Nelson HS, Demoly P.
    J Allergy Clin Immunol; 2013 Dec 17; 132(6):1322-36. PubMed ID: 24139829
    [Abstract] [Full Text] [Related]

  • 16. Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma.
    Eifan AO, Calderon MA, Durham SR.
    Expert Opin Biol Ther; 2013 Nov 17; 13(11):1543-56. PubMed ID: 24099116
    [Abstract] [Full Text] [Related]

  • 17. Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic Patients.
    Nevot-Falcó S, Mancebo EG, Martorell A, Calatayud CM, Perotti SC, Rojas MJ, Rodriguez-Rodriguez M, Padial MA, El Qutob Lopez FD, Perez-Camo I, Gomez-Brenosa B, Cano MDMG, Gonzalez de Olano D, Ferre-Ybarz L, López FF, Lara Jiménez Á, Aldunate-Muruzabal T, Pascual MC, Villas F, Garcia EC, Reche M, Antolin-Amerigo D, Barbarroja-Escudero J, Romero EN, Ruiz-Garcia M.
    Int Arch Allergy Immunol; 2021 Nov 17; 182(12):1226-1230. PubMed ID: 34392241
    [Abstract] [Full Text] [Related]

  • 18. Patient initiation and persistence with allergen immunotherapy.
    Anolik R, Schwartz AM, Sajjan S, Allen-Ramey F.
    Ann Allergy Asthma Immunol; 2014 Jul 17; 113(1):101-7. PubMed ID: 24814759
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review.
    Rice JL, Diette GB, Suarez-Cuervo C, Brigham EP, Lin SY, Ramanathan M, Robinson KA, Azar A.
    Pediatrics; 2018 May 17; 141(5):. PubMed ID: 29572287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.